Researchers found that a new drug combination may help with weight loss while preserving muscle. Metashape Pharma is set to present exciting preclinical data on MS 001, an experimental drug, combined with semaglutide, a well-known diabetes medication, at the upcoming American Diabetes Association conference in June 2026. This combination aims to enhance fat loss while keeping muscle mass intact, which is crucial for anyone looking to maintain strength and health as they age.

This discovery matters for people who want to manage their weight effectively and maintain their muscle as they get older. Losing weight while preserving muscle is particularly important for older adults, as muscle loss can lead to weakness and increased risk of falls. The preclinical study showed that this drug combination led to increased thermogenesis (the process of heat production in organisms) and selective fat loss in mice that were fed a high-fat diet. While the effects in mice are promising, they suggest that this approach might help people achieve their weight loss goals without sacrificing muscle.

However, it’s important to note that this research is still in the early stages. The findings come from studies in mice, meaning they are not yet proven in humans. While the results are encouraging, more research is needed to determine if the same benefits will be seen in people. Until then, it’s wise to stay informed about developments in this area, especially if you’re looking for effective ways to manage weight and maintain muscle as you age.

Source: longevity.technology